Q-Linea AB (QLINEA) Stock Overview

Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. It offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. The company serves healthcare providers. Q-linea AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.